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1. Introduction
  Malaria is an ancient vector-borne disease of humans and other 
primates caused by a highly complex protozoan belonging to 
the genus Plasmodium[1,2]. Female Anopheles mosquitoes are 
insect vector for transmitting the disease in humans. The disease 
is endemic to more than 100 countries throughout tropical and 
subtropical zones. Recently, the world malaria report  released by 
world  health organization has estimated that around 3.4 billion 
people are at risk of  malaria  and  about 207  million  cases  of 
malaria  occurred  globally during 2013[3]. In Africa significant 
numbers of child death has been directly attributed to malaria. A 
research suggests that majority of malaria-associated deaths globally 
were children less than 5 years of age from sub-Saharan Africa[4]. 
Nonetheless, even after several decades of the disease control 
campaigns, malaria persists as one of the most serious public health 
problem not only in endemic countries but also in non-endemic 
regions where the increasing number of imported malaria cases via 
tourists and immigrants are on the rise[5].
  Four species of the pathogen namely: Plasmodium vivax (P. vivax), 
Plasmodium falciparum (P. falciparum), Plasmodium malariae, and 
Plasmodium ovale (P. ovale) are highly distributed among malaria-
affected regions in the world. In addition, recently discovered 
Plasmodium knowlesi-associated zoonotic form of human malaria in 
Southeast Asia is also creating serious concerns among pathologist 
and epidemiologists[6]. Among the species, P. falciparum accounts 
almost all of the malaria-associated mortality [7,8]. Malarial 
pathogen has exceptional ability to adopt and maintain a complex 
parasite life cycle in both humans and Anopheles spp. with several 
morphologically and functionally distinct extra- and intra-cellular 
stages. In addition, mutational selection resulting into drug resistant 
strains of the parasite, the spread of insecticide resistant mosquitoes 
and lack of effective vaccines against the Plasmodium spp. are some 
of the critical barriers preventing eradication of this disease[9].
  Morbidity and mortality caused by the disease is exclusively 
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associated with the erythrocytic stage of infection where the 
pathogen continuously undergoes intracellular development and re-
invasion into red blood cells (RBCs) resulting in exponential parasite 
proliferation. If untreated, the disease progressively causes severe 
haemopenia, kidney failure, mental confusion,seizures, coma, and 
death[10,11]. Multiple neurological complications and cognitive 
deficits can arise specially during cerebral malaria as the parasite 
can also infect brain. In addition, the parasite is known to constantly 
develop resistance against antimalarial drugs making it more 
difficult to cure the disease[12].  Hence, it is clear that early diagnosis 
and prophylaxis has a major role in preventing malaria-associated 
mortality. Even though several rapid detection tests (RDTs) and 
kits are available for screening malaria infection, their efficiency 
and accuracy are still questionable. Thus, there is a growing need 
for exploring new detection techniques that are highly sensitive and 
portable for early identification of malaria. In this context, an in-
depth study of potential biomarkers associated with malaria pathogen 
can be crucial for identification of a suitable biorecognition element 
and its implementation for devising a robust and reliable diagnosis 
technique for early detection of the disease. Here, we briefly discuss 
on the current prospect and future potential of biomarkers and 
different proteomic approaches that can be used for malaria research.
2. Drugs used for treatment of malaria 
  Parasite causing malaria exhibits astonishing adoption abilities 
and due to prevalence of several species, strains, and variants the 
treatment of malaria is not always easy. Even today, the choice of 
drugs for effective medication is quite limited and drug resistant 
strains of this pathogen are on the rise[12,13]. The drug of choice 
Aralen (Chloroquine phosphate) is effective for all malarial parasites 
except for chloroquine-resistant Plasmodium strains[9]. Traditional 
medication for P. falciparum-mediated malaria involved the use 
of sulphadoxine-pyrimethamine (SP) or chloroquine. However, 
the over-dependence and excess use of both quinoline compounds 
(amodiaquine, chloroquine, mefloquine, and quinine) and 
antifolatedrugs (chlorproguanil, sulphonamides, and pyrimethamine) 
have led to cross-resistance among these compounds[14,15]. 
Emergence of such resistant strains of P. falciparum has motivated 
to switch towards new class of artemisinin-derived antimalarial 
compounds. Currently, the artemisinin-derived combination therapies 
(ACTs) which involves use of artemisinin derivatives in combination 
with other traditional antimalarial drugs, is regarded as the best 
treatment option[16]. For P. vivax and P. ovale which are known to 
possess dormant stages and can cause relapses, primaquine is often 
administered in addition to ACTs. Unfortunately, any therapy is not 
always guaranteed to work against the disease since several strains 
of the parasite resistant even to ACTs have been reported in different 
parts of the world[16,17]. Although several strategies and multiple 
drug treatment protocols do exist to prevent drug resistant malaria, 
detecting the disease at its early stage remains vital for the successful 
treatment. Hence, in this scenario the importance of biomarker-
based technique for timely diagnosis of the disease becomes more 
essential.
 
3. Role of biomarkers in malaria diagnosis
  Biomarkers can be defined as any measurable changes for 
molecular, biochemical or cellular alternations in biological samples 
that can indicate biological, pathological or therapeutic responses[18]. 
Possibility to detect certain biomarkers for Plasmodium-mediated 
infection at early stages of malaria can be crucial for formulating 
disease management strategies and choosing correct prophylaxis 
for the disease[19]. Typically for the endemic zones of Africa 
where asymptomatic malaria is rampant, such biomarker-based 
detection techniques combined with proper treatment strategies 
may significantly help deplete human reservoirs of the parasite 
that frequently contributing to persistence of malaria transmission 
in such areas[19-21]. Current advancement in proteomics and 
immunotechnology has provided vital tools for in-depth study and 
analysis of different human body fluids including saliva, urine, and 
serum. In general, analysis of proteome from such fluids provides a 
valuable resource for the identification of potential disease-related 
markers. The host immune response against the disease condition 
can exhibit rapid alteration in expression pattern unique for a 
pathogen which may be directly correlated with disease progression 
at its early state[22]. The use of biomarkers provides us with sensitive 
and effective means for investigation of disease pathogenesis. 
Currently, several malaria-associated biomarkers have been utilized 
for the disease identification and few of them are briefly described 
below.
3.1. P. falciparum lactate dehydrogenase (PfLDH)
  Plasmodium is a voracious scavenger of blood glucose that can 
force the RBC to increase glucose consumption up to 100-fold 
during intraerythrocytic cycle. Microarray experiments using P. 
falciperum transcriptome has shown that all enzymes in glycolytic 
pathway are significantly upregulated during early trophozoite stage 
correlating with the high metabolic state of the pathogen at this 
particular stage of its asexual life-cycle[23]. In particular, the enzymes 
involved in energy metabolism during the intraerythrocytic stages 
of the parasite lack a functional citric acid cycle, and production 
of ATP depends fully on the glycolytic pathway[24]. Among other 
enzymes, the pathogen seems to principally rely on PfLDH as its 
essential enzyme in glycolytic pathway to convert pyruvate into 
lactate[25]. The PfLDH RNA expression level gradually increases and 
reaches its peak within 24 to 30 hours of infection during the intra-
erythrocytic cycle. This expression subsequently declines tozero 
in the schizont stage[20,26]. Since the Plasmodium LDH (pLHD) 
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contains some major structural differences compared to human form 
of enzyme, this biomarker holds therapeutic potential to formulate 
promising antimalarial drug targets or diagnostic tools[27,28]. The 
malarial LDHs of parasite has been discovered to contain five-
residue aminoacid insert known as D-aspartic acid, E-glutamic acid, 
K-lysin, W-tryptophan, and N-asparagine (DKEWN) on one of 
its active site and the insert has also been employed as a common 
diagnostic epitope for PfLHD[29,30]. Contrary to the human LHDs, 
investigation of enzyme kinetics has revealed that the pLDH enzyme 
is not significantly affected by the excess substrate pyruvate[31]. 
This feature of reduced substrate inhibition is attributed to a single 
amino acid substitution in the Plasmodium enzyme (Ser163Leu). 
The pLDH is particularly distinguished from mammalian LHD due 
to presence of long substrate specificity loop[31,32]. It is clear that 
pLHD with its unique structural features, metabolic differences, and 
enzyme kinetics presents as an attractive biomarker for antimalarial 
drug design.
3.2. Histidine-rich proteins (HRPs)
  The HRPs relating to Plasmodium were first discovered during the 
analysis of cytoplasmic granules from the avian malaria parasite 
Plasmodium lophurae. The polypeptides in granules contained 
abnormally high levels of histidine reaching upto 73% in total[33]. 
There are three major types of HRPs associated with Plasmodium 
parasite and named according to the order of their discovery[24,34]. 
The HRP1 is basically aKnob-associated protein present in Knob-
positive strains of the parasite and is known to assist coadhereance of 
infected erythrocyte to venular endothelial cells[20,35]. The HRP2 is 
regarded as a vital biomarker unique to P. falciparium and is present 
in both Knob-positive and -negative strains of the parasite that 
causes the most severe form of malaria[36]. The P. falciparum HRP2 
(PfHRP2) is known to exhibit many functions including tightly 
binding with glycosaminoglycans (heparan sulfate,dermatan sulfate, 
and heparin) causing inhibition of antithrombin and detoxification 
of heme by forming haemozoin[2]. HRP2 has remained one of 
the prime targets for development of antimalarial drugs and rapid 
diagnostictests (RDTs) as evidence shows that PfHRP2-based assays 
are more sensitive towards detection of P. falciparum than aldolase- 
and LHD-based diagnostic tests[37]. However, the P. falciparum
from Asia-Pacific region is known to express high variability 
in PfHRP2, which has posed significant difficulty for the 
development of efficient malaria RDTs development[38]. 
Lastly, the HRP3 is not as common as HRP1 and HRP2.
P. falciparum HRP3 (PfHRP3) is a small histidine-rich protein 
(SHARP) that shares several structural homology with PfHRP2. It 
has been suggested that both PfHRP2 and PfHRP3 were derived 
from duplication and interchromosomal divergence from a common 
ancestral gene[38-40]. Due to structural homology, several antibodies 
against PfHRP2 are known to cross-react with PfHRP3, and thus 
contributing to the detection of P. falciparum[41,42]. Overall, the 
Plasmodium-associated HRPs constitute a prominent biomarker for 
malaria diagnosis.
3.3. Haemozoin
  Haemozoin is often known as malaria pigment as it is a visible 
marker in detection of malarial parasite. It is a non-toxic insoluble 
microcrystalline by-product formed by polymerizing free-toxic 
heme after digestion of haemoglobulin by Plasmodium and some 
other RBC-feeding parasites[10,43,44]. Several currently available 
antimalarial drugs including mefloquine and chloroquine act 
by blocking the haemozoin biocrystallization that kills malaria 
parasite[45]. Even though the exact process for formation of 
haemozoin is barely understood, the HRP2 is suggested to assist 
initiation of haemozoin formation by firmly binding to heme 
molecules and initiating their polymerization. However other 
haemozoin synthesis mechanism based on neutral lipid bodies 
and polar membrane lipids have also been reported[46-48]. As 
the haemozoin formation is crucial for the parasite survival, it 
has therefore become a prominent target for antimalarial drug 
development.
3.4. Plasmodium aldolase
  Proteins and enzymes associated with the glycolytic pathways of the 
Plasmodium has remained a prime focus for parasite detection and 
antimalarial drug development. Aldolase has a vital role in cleavage 
of fructose-1,6-bisphosphate into glyceraldehyde-3-phosphate 
and dihydroxyacetone phosphate in the glycolytic pathway of the 
parasite. The Plasmodium aldolase is a homotetrameric in nature 
with each subunit of approximately 40 kDa[49]. Unlike vertebrates 
which comprise three tissue-specific aldolase enzymes, the P. vivax 
and P. falciparum contain only one type of aldolase isozyme. The 
enzyme is 369 amino acids in length and their nucleotide and amino 
acid sequences are relatively conserved[50,51]. The enzyme can be 
found either as an insoluble membrane-bound aldolase or localized 
in cytoplasm of the parasite as an active and soluble form[49]. The 
plasticity of active-site region and multimeric nature of the enzyme is 
also suggested for its intriguing non-enzymatic activity for assisting 
the invasion machinery of the malaria parasite[52]. The Plasmodium 
aldolase exhibits drastic difference from the host enzyme and thus 
has been utilized in several commercially available RDTs. Even 
though several reports have suggested that aldolase-based diagnostic 
tests provide relatively lower sensitivity as compared to HRPs-
based tests, the enzyme remains a vital target for disease diagnosis 
and drug development[53]. Thus, the Plasmodium aldolase has been 
regarded as prominent biomarker in malaria research.
3.5. Glutamate dehydrogenase (GDHs)
  The GDHs are ubiquitous enzymes responsible for the reversible 
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oxidative deamination of L-glutamate for production of 毩
-ketoglutarate and ammonia utilizing NAD (H) or NADP (H) 
as co-factors[54]. The enzyme serves as a branching point of 
nitrogen-carbon metabolism as it can either assimilate ammonia 
and provides glutamate for storage of nitrogen or dissimilates 
ammonia and generates 毩-ketoglutarate as a feed for tricarboxylic 
acid metabolism. Since malaria parasite exhibits different 
isoforms of GDHs, these enzymes are considered as an important 
biomarker for malaria diagnosis.Both NADP- and NAD-
dependent GHDs are present in Plasmodium. In particular, the
P. falciparum exhibits three types of isozymes encoding GDHs. 
Two genes gdha and gdhb encoding potential GDHs are located in 
chromosome 14 and the third gene gdhc is present in chromosome 
8[7,54]. The Plasmodium GDHs contains N-terminal residue unique to 
the parasite that is present throughout intra-erythrocytic cycle of the 
pathogen. As RBCs do not contain GDHs, it can potentially serve 
as a biomarker for disease diagnosis[55,56]. Techniques involving 
western blotting, immunochromatographic assays have been utilized 
to detect the parasite utilizing GDHs[8,57]. Hence, the GDHs may be 
considered as a significantly important disease-associated biomarker 
for malaria diagnosis and treatment.
4. Role of proteomics in malaria research 
  Proteome generally refers to the entire set of proteins belonging 
to a cell or an organism which can vary with time depending on 
distinct requirements or stresses that it endures[58]. Proteomics 
provides necessary tools for large-scale experimental analysis of the 
proteome for generating data on relevant protein sets from pathogen 
and the host[59]. This information can help understand the host-
parasite relation in context to the structures, specific expressions, and 
functions of the proteins. The past decade has witnessed astonishing 
increase in study and global shearing of knowledge on Plasmodium 
proteome leading to establishment of global protein database of 
malaria parasite[60]. This has significantly helped researchers by 
assisting identification of potential targets for antimalarial drugs that 
specifically interrupt the host-parasite interaction and thus prevent 
disease development[61]. Reports have suggested that the survival of 
malaria parasite requires tight regulation of several proteins during 
different stages of its life-cycle in both vertebrate and invertebrate 
host[1,61]. However, most of today’s modern technologies in 
proteomics for detection and prevention of malaria are focused on 
intra-erythrocytic stage of the parasite life-cycle which is the major 
cause of malaria-associated mortalities[59]. Thus, the techniques 
that can be applicable both for research and clinical diagnosis of 
malaria are of immense importance for combating this disease.Some 
of the major modern proteomics-based approaches for research on 
pathogenesis and diagnosis of Plasmodium infection are summarized 
below.
4.1. One dimension sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (1D SDS-PAGE) approach in malaria 
research
  Proteomic approach requires identification and ascertaining 
the protein population that are differentially expressed and also 
detection of any post-translational modifications that occur during 
each stage of parasites life-cycle[11,62]. The1D SDS-PAGE is a 
widely used technique in molecular biology to separate biological 
macromolecules, usually proteins or nucleic acids (Figure 1). 
The technique has been frequently employed for separating and 
analyzing various protein fractions from trophozoite stage of P. 
flaciparum[11]. In addition, it has also been used for identification of 
phosphorylated protein pattern by separation of phosphoproteome 
of P. falciparum parasitized RBCs[63]. The method has application 
in protein separation for detection of distinct patterns of blood-
stage Plasmodium antigens using plasma immunoglobulin-G (IgG) 
subclasses from individuals with different level of exposure to P. 
falciparum infections[64]. The 1D-SDS PAGE has remained a well-
adopted method for separating the protein fractions derived from 
Plasmodium-infected samples to enhance sensitivity and resolution 
of protein identification prior to mass spectrometry[63,65]. Taken 
together, the 1D SDS-PAGE presents itself as a simple yet highly 
applicable technique for study of malaria proteomics.  
Figure 1. Schematics of one dimensional SDS-PAGE.
The sample containing protein mixtureis treated with ionic detergent sodium 
dodecyl sulfate (SDS) which denatures and binds to proteins in a fixed charge 
to mass ratio making them evenly negatively charged. The samples are then 
added to wells at the top of the polyacrylamide gel. The electric field is then 
applied which causes different proteins to separate into bands as they move 
down through the gel matrix. These bands of separated proteins can then be 
stained and compared or even used for other detection steps.
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4.2. Two dimensional SDS-PAGE (2D SDS-PAGE) 
approach in malaria research
  The 2D SDS PAGE is a widely used two-dimensional gel 
electrophoresis (2-DE) technique for investigating P. vivax and P. 
falciparum infected blood samples[66,67]. It is also one of the most 
commonly used methods for obtaining a snapshot of proteome at the 
specific time of infection. A basic schematic of the assay is given in 
Figure 2. Customized forms of 2D SDS-PAGE has been utilized as a 
semiquantative gel electrophoresis technique for assisting proteomic 
profiling of P. falciparum[68]. In addition, the mass spectrometry-
based techniques such as matrix-assisted laser desorption/ionization 
time of flight (MALDI-TOF) preferentially require the samples to be 
pre-processed using 2D SDS-PAGE for analyzing the bimolecular 
content in high resolution[63,69]. Moreover, the first pioneering 
study on protein maps from proteomes of merozoites and schizonts 
of P. falciparum were obtained utilizing 2D-PAGE and mass 
spectrometry[70,71]. Recently, the 2D SDS-PAGE approach along 
with immunoflurosence assay has been utilized to identify and 
investigate the expression and localization of a relatively conserved 
heat shock protein in malaria parasite[72]. Likely, in a separate report, 
the 2-DE has been implemented as a method of choice for proteomic 
approach to study malaria by investigating protein expression pattern 
in P. falciparium under treatment of antiplasmodial drug such as 
quinine and mefloquine[73]. Thus, is it clear that 2-DE serves as an 
essential tool for malaria research with proteomic approach. 
4.3. Liquid chromatography-tandem mass spectrometry (LC-
MS/MS)
  The LC-MS/MS is basically a hybrid analytical technique that 
contains physical separation capabilities of high performance liquid 
chromatography (HPLC) to fractionate the samples into individual 
analytes while retaining mass analysis capabilities of tandem 
mass spectrometry to quantitate these analytes[74]. A generalized 
schematic of the technique is given in Figure 3. The quest for rapid 
screening of multi-biomarker profiles for various diseases diagnosis 
has led to increasing use of LC-MS/MS for both clinical and 
research purpose[75]. The technology enables researcher to undertake 
advance proteomic approaches by investigating large-scale protein 
expression profiles with high accuracy for complex organism like 
Plasmodium. The LC-MS/MS in combination with 1D-SDS PAGE 
has previously been used for proteomic analysis of salivary gland 
proteins extracted from urban malaria vector Anopheles stephensi[76]. 
Similarly, the technique has also been employed for investigation 
of the P. vivax schizont stage proteome in humans for identification 
of immunogenic proteins that may hold therapeutic potentials[62]. 
Their computational research data provided first direct insight into 
identification and functional characterization of salivary proteins[76]. 
LC-MS/MS analysis of P. falciparum extracellular secretory proteins 
produced during asexual blood stages of parasite has assisted in 
revealing numerous proteins potentially involved in host immune 
modulation and signaling[77]. In addition, the technique has also 
been utilized for study of plasma and cerebrospinal proteomes from 
children acquiring cerebral malaria for better understanding of 
pathogenesis and helps develop more-specific diagnostic methods[78]. 
Hence, the technique can be regarded as a rapid yet highly efficient 
tool for large-scale proteomic analysis for malaria.
Figure 2. Schematics of  two dimensional SDS-PAGE. 
The process contains two major steps. At first the sample is loaded on a thin 
gel having pH gradient and electric current is applied which separates the 
proteins according to their isoelectric point (pI). At this point, the pI of a 
given protein is in equilibrium with pH of the gel. In the next step, the gel 
strip is then loaded onto another polyacrylamide gel and second electric 
current is applied in a direction perpendicular to the first. In this case, the 
proteins previously separated according to their pI migrates from initial gel 
into the second gel and resolve depending on their masses. The separated 
proteins appear as a spot which can either be stained and visualized or used 
for further detection steps.
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Figure 3. Schematics of LC-MS/MS.
The samples are initially separated using SDS-PAGE to obtain bands of 
protein followed by enzymatic digestion. After digestion, the resultant 
product of individual band or whole lane is subjected to multi-dimensional 
liquid chromatography (LC/LC) for further separation of the mixture. The 
elute obtained from LC/LC unit is further ionized using EI-Unit. Each 
elute peak can be then analyzed for its mass using MSU-1. Likely, for 
determination of peptide unit, the elute peak is subjected to MSU-2 where 
it is first separated in MS-1 and passes through collision chamber where it 
is further fragmented and subsequently analyzed by MS-2. Finally, the data 
from MS-2 is computed to obtain peptide sequence.
4.4. MALDI-TOF
  The technique is based on ionization of biomolecules, generally 
proteins, in samples, followed by analysis of its constituent 
using specially designed mass spectrometric equipment that 
utilizes high energy collision-induced dissociation to investigate 
amino acid sequence of peptides [79]. Figure 4 represents 
generalized schematics of MALDI-TOF mass spectrometry 
(MS). Due to its accuracy, speed and cost effectiveness, the 
technique has been successfully employed as an identification 
procedure in clinical microbiology and also widely implemented 
in routine laboratory practices [79,80]. The technique along 
with SDS-PAGE has been applied for characterization of the
P. vivax erythrocytic stage proteome and identification of a relatively 
stable protein PV180L as a potent immunogenic antigen during the 
erythrocytic cycle of malaria parasite[81]. Previously, it was reported 
that the method had been employed to assist analysis of recombinant 
P. vivax merozoite surface antigen protein that was allowed to 
be expressed in Escherichia coli for malaria vaccine development 
research[82]. Recently, MALDI-TOF has been employed for rapid 
identification of Anopheles mosquitoes from its leg protein samples 
and has been able to generate several sets of biomarkers for its 
precise identification[83]. The P. falicaprum and P. vivax proteomes 
subjected to MALDI-TOF analysis have revealed several proteins 
that are differentially expressed and are potentially important for 
studying disease pathogenesis[66]. In a separate report, the technology 
has been applied to assist identification and extend the knowledge 
on redox proteins such as pthioredoxin, glutaredoxin and plasm 
oredoxin for better understanding of redox interactome in malarial 
parasites[84]. Thus, reports presented here clearly demonstrate that 
MALDI-TOF is a relevant tool for studying malaria proteomics and 
opens new avenues for both clinical diagnosis and experimental anti-
malarial drug development.
Figure 4. Schematics of MALDI-TOF.
Samples are initially processed using SDS-PAGE to obtain bands of protein 
which is then enzymatically digested. The resultant product of individual 
band or whole lane is subjected to MALDI-TOF MS where the proteins 
placed on matrix molecule in solution are allowed to undergo soft ionization 
using laser. The ions from protein accelerate under the influence of electric 
field as they pass on through the time-of-flight tube where the charge-to-
mass ratio of each ion is determined using time measurement by the detector. 
Finally, the data is computed to determine the mass and polypeptide sequence 
of the protein.
4.5. Surface-enhanced laser desorption/ionization time of 
flight (SELDI-TOF)
  The SELDI-TOF MS is a modified form of MALDI-TOF that 
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utilizes target surface modified to achieve biochemical affinity 
and selectively analyze samples based on their affinity towards the 
surface matrix[85,86]. Generalized schematic of the technique is 
given in Figure 5. One of the obvious advantages of this surface-
enhanced process is that components, such as salts or detergents 
that commonly cause problems with other analytical tools, are 
removed prior to analysis[87]. The technology is characterized 
by its rapid diagnostic capabilities that can be applied to study 
proteomes to discover biomarkers associated with parasitic diseases 
which may include host proteins or protein fragments derived from 
parasite or host, in body fluids or tissues following infection[88]. 
In comparison with other proteomic techniques, SELDI-TOF 
has several key advantages including ability to analyze complex 
biological samples with minimal pre-processing, ease of handling, 
and high throughput[86]. The method had been used for protein 
expression profiling to identify chloroquine resistance markers in P. 
falciparium strains resistant to chloroquine[9]. Recently, the SELDI-
TOF has been used to identify hepcidin, a hepatocyte-associated 
protein having a function of sequestration of iron, from blood plasma 
for its possible role in anti-inflammatory response in childhood 
malaria[89]. The technique has been employed for determining 
urinary hepcidin in malaria patient suffering from uncomplicated P. 
falciparum infection to study the relationship between parasitemia 
and anemia[90]. Moreover, the level of sophistication behind this 
technology has assisted researchers in proteomics to explore 
previously uncharted conditions in patients chronically infected with 
blood-borne protozoan parasites including malaria[88,91]. Thus, it is 
clearly evident that the protein expression profiling approach using 
SELDI-TOF provides a useful tool for understanding the proteome 
of malarial parasites.
5. Conclusion
  The advancement in techniques for investigating proteome 
of Plasmodium and identification of potential biomarkers has 
undoubtedly widened our knowledge on malaria research. Protein 
profiling and characterization of stage-specific proteome of the 
parasite has helped researchers to reveal numerous novel molecules 
that may hold significant potential for targeted therapeutic drug 
development.The level of sophistication and sensitivity offered 
by current technologies for proteomic studies can help researcher 
to deeply explore the malaria pathogenesis and possibly assist 
identification of new targets and strategies for devising reliable 
diagnostic tests.  Overall, the review provides a brief overview on 
the current scenario and future prospects of malaria biomarkers and 
various proteomic approaches used for malaria research. 
Figure 5. Schematics of SELDI-TOF.
Samples are initially allowed to attach and crystallize on specifically designed 
surface matrix of a protein chip for enhancing biochemical affinity of 
specific proteins or analytes from a complex mixture. Array of such protein 
chips are lined into the SELDI-TOF mass spectrometer where the protein 
on matrix is allowed to undergo soft ionization using laser. Once ionized, 
the protein particles accelerate under the influence of electric field as they 
pass on through the tube and charge-to-mass ratio of each ion is determined 
using time-of-flight mass spectrometry by the detector. The resulting data is 
computed to determine the mass and polypeptide sequence of the protein.
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